p2Ca peptide: a self-peptide derived from the enzyme alpha-ketoglutarate dehydrogenase [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
ID Source | ID |
---|---|
PubMed CID | 132457 |
MeSH ID | M0233858 |
Synonym |
---|
lspfpfdl |
l-leucine, n-(n-(n-(1-(n-(1-(n-l-leucyl-l-seryl)-l-prolyl)-l-phenylalanyl)-l-prolyl)-l-phenylalanyl)-l-alpha-aspartyl)- |
142606-55-1 |
p2ca-y4 |
leucyl-seryl-prolyl-phenylalanyl-prolyl-phenylalanyl-aspartyl-leucine |
p2ca peptide |
p2ca |
HY-P0260 |
l-leucyl-l-seryl-l-prolyl-l-phenylalanyl-l-prolyl-l-phenylalanyl-l-aspartyl-l-leucine |
(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-1-[(2s)-2-[[(2s)-1-[(2s)-2-[[(2s)-2-amino-4-methylpentanoyl]amino]-3-hydroxypropanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoyl]amino]-3-carboxypropanoyl]amino]-4-methyl |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (60.00) | 18.2507 |
2000's | 4 (40.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.89) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 10 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |